Home » Topics » Disease categories and therapies » Urology

Urology
RSS

Positive interim data reported for PRX-302

Oct. 9, 2007

FDA special protocol assessment assigned to atacicept pivotal trial

Oct. 8, 2007

Novel tachykinin NK1 receptor antagonists emerge from Tanabe Seiyaku R&D

Oct. 1, 2007

Keryx sells Zerenex licensing to JT and Torii for development and marketing in Japan

Oct. 1, 2007

NexMed files NDA for topically applied alprostadil cream

Sep. 28, 2007

Recordati completes double-blind portion of phase III Urief trial for BPH

Sep. 28, 2007

Allergan to acquire Esprit Pharma and partner with Indevus on Sanctura brand

Sep. 21, 2007

Palatin reacquires full rights to bremelanotide program

Sep. 13, 2007

Positive results for Plethora Solutions' phase II study of PSD-597 for interstitial cystitis

Sep. 10, 2007

Novel ATP-sensitive potassium channel activators emerge from Janssen R&D

Sep. 6, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
New evidence links autoimmunity to long COVID symptoms
BioWorld
Recent findings are reshaping current understanding of the post-infection landscape of SARS-CoV-2. Although previous studies had already suggested that...
Will Ovid’s golden age of KCC2 metamorph CNS?
BioWorld
The “deep dive” April 8 by Ovid Therapeutics Inc. into potassium-chloride co-transporter 2 (KCC2) research included company officials and independent experts in...
Breakthrough as GSK’s bepirovirsen clears 19% of chronic hep B infections
BioWorld
GSK plc has announced a breakthrough in the treatment of chronic hepatitis B, reporting a functional cure rate of 19% across two phase III trials of its antisense...